NCT05741385View on ClinicalTrials.gov

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

August 9, 2024

Study Completion Date

August 23, 2024

Conditions
Liver Cirrhosis
Interventions
DRUG

Caffeine

Caffeine

DRUG

Warfarin sodium

Warfarin sodium

DRUG

Omeprazole

Omeprazole

DRUG

Metoprolol

Metoprolol

DRUG

Midazolam

Midazolam

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05741385 - A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | Biotech Hunter | Biotech Hunter